2 paramedics struck by car in Las Vegas have returned to Sask. with massive medical bills
Two young Saskatchewan women who went to Las Vegas to celebrate a birthday and their recent graduation as paramedics — and were hit by a car at a crosswalk in the city — are now back in their home province.
On top of multiple broken bones and a lot of pain, Katrine Sinclair and Charlie Listowski were left with huge medical bills for the treatment they received at a U.S. hospital.
Roberta Sinclair, Katrine's mother, said Katrine's bill after two to three days in the hospital was $144,000 US.
"I actually wrote a cheque and my hands were shaking," Roberta said on CBC Saskatchewan's The 306. "I wrote a cheque for $21,621. I've never written such a big cheque in my life."
Roberta said she was surprised to receive an invoice for treatment upfront.
"We Canadians never see the cost up front for a medical [expense] and in the States they hand you an invoice with itemized items," she said. "My daughter had to have six CT scans for $38,000 to $40,000 [US]."
Meanwhile, the air ambulance they used to transfer her daughter ended up costing around $45,000 US.
"It's incredible the cost, but this was a situation where [we thought] you know what, we need to do this," said Roberta. "You cannot put a price tag on your child's life."
Family, friends and community members have raised close to $90,000 via a GoFundMe campaign started by a family friend of Sinclairs.
With the women now back in Saskatchewan, Roberta said they are finding more fractures and broken bones as the swelling goes down.
Katrine has a broken right humerus, one broken rib on her right side, three pelvis fractures, L3, L4, L5 vertebrae fractures and a tibia plateau fracture.
Being a paramedic has helped Katrine accurately assess her pain for doctors.
"She's able to analyze herself," Roberta said. "She was saying, 'My knee is really sore. It's more swollen. This isn't right.' I think that's one of the biggest things she says is they're listening to her."
Roberta used a line of credit to help pay some of the hospital bill and the air ambulance. She thanked the community, first responders and people who have donated.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
10 hours ago
- Cision Canada
ClariMed Inc. Acquires We Are Human, Expanding Growth into Southeast Market
We Are Human's Expert Team and Atlanta-Based Usability Lab Join ClariMed's Growing Network; Founder Annmarie Nicolson Appointed as Principal CHADDS FORD, Pa., Aug. 12, 2025 /CNW/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced the strategic acquisition of We Are Human, a UK and US-based consultancy specializing in user-focused design and research in MedTech innovation. The acquisition expands ClariMed's geographic reach into the Southeast through We Are Human's state-of-the-art Atlanta research facility while advancing the company's mission to enable innovative, human-centered medical technologies and make them accessible to communities that need them. Annmarie Nicolson, founder of We Are Human, will join ClariMed as Principal, bringing her extensive experience in early-stage formative research, contextual inquiry, and UX research for MedTech innovation to the leadership team. The acquisition brings the complete We Are Human team and their Atlanta research facility into the ClariMed family, expanding the company's presence in the Southeast region. "This acquisition represents our continued commitment to our user-centered foundation while expanding our reach and strengthening our capabilities," said Kelley Kendle, CEO of ClariMed."Regional variability allows us to better address our patients' needs and advance our mission to make medical technology safer, more intuitive, and more impactful for the people who need it most. This isn't just a merger of capabilities — it's a deep alignment of values." The acquisition strengthens ClariMed's position as an integrated medical device services partner, expanding specialized expertise in user experience research, regulatory compliance, and design validation across both US and UK markets. We Are Human brings ISO 13485 certification and extensive experience with IEC-62366 and FDA Guidance requirements, having conducted research with hundreds of healthcare professionals, lay persons and diverse patient groups. The Atlanta laboratory will serve as ClariMed's newest research facility, offering access to diverse study populations in the Southeast while supporting the company's growing client base. "Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design," said Annmarie."Both organizations have a long-standing commitment to putting users first and creating products that truly make a difference in people's lives. This shared dedication to excellence and user-centered principles positions us to deliver even more meaningful solutions- both to our clients and, to the patients and healthcare providers who rely on innovative medical technology every day." The integration of We Are Human establishes ClariMed's first Southeast location, joining strategic offices across the United States and internationally, including Chadds Ford, PA; Cambridge, MA; San Jose, CA; Cambridge, UK; Leeds, UK; and now Atlanta, GA. This expanded geographic network enhances ClariMed's ability to serve global clients while accessing diverse talent pools and participant populations for user research and usability testing. This acquisition aligns with ClariMed's growth strategy of building comprehensive, human-centered solutions for medical device development. The combined expertise of both organizations positions ClariMed to better serve pharmaceutical and medical device manufacturers seeking to accelerate time to market while enhancing patient safety and user experience. About ClariMed ClariMed is a human-centered development and regulatory practice for medical products developed by pharmaceutical and medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. With offices across the United States and United Kingdom, ClariMed delivers comprehensive solutions that integrate human factors at the core of device development and regulatory pathways. Visit us at About We Are Human Founded in 2020, We Are Human is an ISO 13485 certified consultancy, based in the UK and US specializing in Human Factors, User Research and UX, with deep expertise in human-centered research and design for healthcare. The company was founded on the belief that human needs should be at the heart of design, striving to improve quality of life, health, and wellbeing through product development. We Are Human brings extensive experience in Human Factors and Usability Engineering standards and regulatory requirements for medical device development, including IEC-62366 and FDA Guidance, with a track record of collaborating with clients across Medical Devices, Combination Products, FemTech, Digital Health and over-the-counter (OTC) products.


Globe and Mail
10 hours ago
- Globe and Mail
ClariMed Inc. Acquires We Are Human, Expanding Growth into Southeast Market
We Are Human's Expert Team and Atlanta-Based Usability Lab Join ClariMed's Growing Network; Founder Annmarie Nicolson Appointed as Principal CHADDS FORD, Pa. , Aug. 12, 2025 /CNW/ -- ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, today announced the strategic acquisition of We Are Human, a UK and US-based consultancy specializing in user-focused design and research in MedTech innovation. The acquisition expands ClariMed's geographic reach into the Southeast through We Are Human's state-of-the-art Atlanta research facility while advancing the company's mission to enable innovative, human-centered medical technologies and make them accessible to communities that need them. Annmarie Nicolson , founder of We Are Human, will join ClariMed as Principal, bringing her extensive experience in early-stage formative research, contextual inquiry, and UX research for MedTech innovation to the leadership team. The acquisition brings the complete We Are Human team and their Atlanta research facility into the ClariMed family, expanding the company's presence in the Southeast region. "This acquisition represents our continued commitment to our user-centered foundation while expanding our reach and strengthening our capabilities," said Kelley Kendle , CEO of ClariMed. "Regional variability allows us to better address our patients' needs and advance our mission to make medical technology safer, more intuitive, and more impactful for the people who need it most. This isn't just a merger of capabilities — it's a deep alignment of values." The acquisition strengthens ClariMed's position as an integrated medical device services partner, expanding specialized expertise in user experience research, regulatory compliance, and design validation across both US and UK markets. We Are Human brings ISO 13485 certification and extensive experience with IEC-62366 and FDA Guidance requirements, having conducted research with hundreds of healthcare professionals, lay persons and diverse patient groups. The Atlanta laboratory will serve as ClariMed's newest research facility, offering access to diverse study populations in the Southeast while supporting the company's growing client base. "Joining ClariMed represents an exciting opportunity to amplify our impact in healthcare through human-centered research and design," said Annmarie. "Both organizations have a long-standing commitment to putting users first and creating products that truly make a difference in people's lives. This shared dedication to excellence and user-centered principles positions us to deliver even more meaningful solutions- both to our clients and, to the patients and healthcare providers who rely on innovative medical technology every day." The integration of We Are Human establishes ClariMed's first Southeast location, joining strategic offices across the United States and internationally, including Chadds Ford, PA ; Cambridge, MA ; San Jose, CA ; Cambridge, UK ; Leeds, UK ; and now Atlanta, GA. This expanded geographic network enhances ClariMed's ability to serve global clients while accessing diverse talent pools and participant populations for user research and usability testing. This acquisition aligns with ClariMed's growth strategy of building comprehensive, human-centered solutions for medical device development. The combined expertise of both organizations positions ClariMed to better serve pharmaceutical and medical device manufacturers seeking to accelerate time to market while enhancing patient safety and user experience. About ClariMed ClariMed is a human-centered development and regulatory practice for medical products developed by pharmaceutical and medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. With offices across the United States and United Kingdom , ClariMed delivers comprehensive solutions that integrate human factors at the core of device development and regulatory pathways. Visit us at About We Are Human Founded in 2020, We Are Human is an ISO 13485 certified consultancy, based in the UK and US specializing in Human Factors, User Research and UX, with deep expertise in human-centered research and design for healthcare. The company was founded on the belief that human needs should be at the heart of design, striving to improve quality of life, health, and wellbeing through product development. We Are Human brings extensive experience in Human Factors and Usability Engineering standards and regulatory requirements for medical device development, including IEC-62366 and FDA Guidance, with a track record of collaborating with clients across Medical Devices, Combination Products, FemTech, Digital Health and over-the-counter (OTC) products.
Montreal Gazette
12 hours ago
- Montreal Gazette
Fitness: If you build it, they will cycle
The last several decades have seen communities across the country slowly increase their cycling infrastructure. Bike paths and bike lanes are designed to promote a more active lifestyle, yet only about one per cent of working Canadians 15 years and older use a bike as their main form of transportation to and from their job. A great way to sneak in exercise during a busy day, active commuting doesn't just mean cycling to the office and back. Biking to the commuter train or tram, to pick up groceries, to the library and/or friends' houses can all add valuable exercise minutes to the day. Some studies report that two hours of cycling a week results in a nearly 10 per cent reduction in mortality, not a bad return for leaving the car at home for short commutes. But the key to getting more people to choose their bike over the car is ensuring they feel safe on the road. In a battle for space on city streets, cyclists are almost always the loser. So dedicated bike paths are the key to creating more bike-friendly cities. But not just any bike path will do. The safer the bike path is perceived, the more likely it is to get used. Studies done in European, American and Australian cities state that dedicated bike paths or routes, a physical separation between cyclists and cars, and the proximity between cyclist and the closest bike path, all play a role in promoting more active transportation. Yet, little is known about how improvements to cycling infrastructure has changed cycling culture in Canada, so a team of researchers, urban planners and public health scientists from Queens, Ottawa and McGill universities and federal public health agencies studied the impact of bike lane safety and improved proximity on cycling behaviour in Montreal. Considered one of the most bike-friendly cities in Canada due to its extensive network of bike lanes and popular bike-share program, Montreal is the ideal city to evaluate the impact of cycling infrastructure on cycling behaviour. And with additions to the city's cycling network, it's also a great choice to evaluate whether adding more bike paths results in more people using bikes in urban settings. 'This study is the first to explore the associations between changes to an entire cycling network and self-reported population-level cycling for transportation and recreation in a Canadian metropolitan area,' said the research team behind the study published in June 2025. Using data from a national health survey that followed respondents from 1994-2011, the researchers highlighted cyclists who reported cycling to work, school, to do errands as well as those who cycle for recreation. Using maps of Montreal cycling routes and bike lanes, the researchers analyzed how cycling behaviour changed while cycling infrastructure improved. They also examined whether the perceived safety of local bike paths had an impact on their use. The researchers defined cycle pathways that are bike-only and physically separated from cars (by bollards, a median or cement curbs) as high comfort, bike paths shared with pedestrians as medium comfort and bike paths on busy roads separated by painted lines as low comfort. Then they quantified and rated all bike paths on their level of safety, gauged their proximity to the respondents' home addresses and tracked the number of Montrealers reported cycling for transportation or recreation over two decades. The results created a complete picture of just how welcoming the streets of Montreal are for cyclists. Not surprisingly, the safer and more convenient the bike lane, the more it was used. 'We found that exposure to high-comfort cycling infrastructure within a predefined acceptable distance threshold was associated with a 28 per cent greater likelihood of engagement in cycling for recreation or transportation,' said the researchers. Medium-comfort bike lanes — sharing a bike lane with pedestrians but still with a physical separation from vehicles — were also well used, especially by recreational cyclists. Interestingly, safer bike lanes saw a greater boost in cycling activity among women than men, a finding replicated by similar studies in other countries. Clearly, adding more cyclists and fewer cars to city streets requires continued investment in bike lanes and cycling safety. It's no longer enough to paint a few lines along a narrow corridor of an existing city street and call it a bike lane. Intentional urban planning with high-to-medium safety bike lanes increases perceived safety, which makes them a better fit for anyone who wants to travel through the city on two wheels instead of four. 'This research further strengthens the evidence in Canada that cycle paths, especially of higher comfort and safety, can promote cycling,' said the researchers. Greater use of bikes in urban environments doesn't just result in healthier and more active communities but can also lead to better air quality and less traffic congestion. Making cities cleaner, safer and easier to navigate is in everyone's favour, even those who don't have plans to trade in their car for a